Mauro Driussi

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Journal: International journal of cardiology

Published: May 13, 2026

Inotropic therapy in outpatients with worsening or advanced heart failure: literature evidence and comparison of Italian management models

Inotropic therapy in outpatients with worsening or advanced heart failure: literature evidence and comparison of Italian management models

Journal: Giornale italiano di cardiologia (2006)

Published: March 25, 2026

Coexistence of hereditary transthyretin amyloid cardiomyopathy and sarcomeric hypertrophic cardiomyopathy: a multimodality imaging and genetic case report.

Coexistence of hereditary transthyretin amyloid cardiomyopathy and sarcomeric hypertrophic cardiomyopathy: a multimodality imaging and genetic case report.

Journal: European heart journal. Case reports

Published: February 03, 2026

Real-World Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Real-World Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Journal: Respiration; international review of thoracic diseases

Published: December 16, 2025

Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis.

Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis.

Journal: JACC. Heart failure

Published: March 20, 2025

Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis.

Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis.

Journal: European journal of heart failure

Published: February 27, 2025

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor.

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor.

Journal: Cardiac failure review

Published: December 22, 2024

Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Journal: International journal of cardiology

Published: December 14, 2024

Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.

Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.

Journal: Chest

Published: November 15, 2024

Impact of an expert-derived, quick hands-on tool on classifying pulmonary hypertension in chest computed tomography: a study on inexperienced readers using RAPID-CT-PH.

Impact of an expert-derived, quick hands-on tool on classifying pulmonary hypertension in chest computed tomography: a study on inexperienced readers using RAPID-CT-PH.

Journal: La Radiologia medica

Published: March 18, 2024

Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension.

Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension.

Journal: ESC heart failure

Published: March 07, 2024

Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction.

Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction.

Journal: Frontiers in cardiovascular medicine

Published: December 01, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026